V029-2163 Screening compound: 2-(2H-1,3-benzodioxol-5-yl)-4-[(2-fluorophenyl)amino]-N-[3-(2-oxopyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide

V029-2163 Screening compound: 2-(2H-1,3-benzodioxol-5-yl)-4-[(2-fluorophenyl)amino]-N-[3-(2-oxopyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide
V029-2163 Screening compound: 2-(2H-1,3-benzodioxol-5-yl)-4-[(2-fluorophenyl)amino]-N-[3-(2-oxopyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-2163
2-(2H-1,3-benzodioxol-5-yl)-4-[(2-fluorophenyl)amino]-N-[3-(2-oxopyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-2163

Molecular Formula

C25H24FN5O4 (C25 H24 FN5 O4)

Compound Name

2-(2H-1,3-benzodioxol-5-yl)-4-[(2-fluorophenyl)amino]-N-[3-(2-oxopyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide

IUPAC name

2-(2H-13-benzodioxol-5-yl)-4-[(2-fluorophenyl)amino]-N-[3-(2-oxopyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide

SMILES

O=C(c1cnc(-c(cc2)cc3c2OCO3)nc1Nc(cccc1)c1F)NCCCN(CCC1)C1=O

InChI

InChI=1S/C25H24FN5O4/c26-18-5-1-2-6-19(18)29-24-17(25(33)27-10-4-12-31-11-3-7-22(31)32)14-28-23(30-24)16-8-9-20-21(13-16)35-15-34-20/h1-2,5-6,8-9,13-14H,3-4,7,10-12,15H2,(H,27,33)(H,28,29,30)

InChI Key

AOVYUFXYEZTMKI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19973558

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

477.5

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.035

Distribution Coefficient, logD

2.955

Water Solubility, LogSw

-3.45

Polar Surface Area

86.797

Acid Dissociation Constant (pKa)

14.89

Base Dissociation Constant (pKb)

6.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.00

V029-2163 in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

Anticancer Library (62698 compounds)

Antiviral HBV Library (10007 compounds)

CORONAVIRUS Library (20774 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

New Agro Library (44492 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Agro:
  • Agro
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V029-2163 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-2163?
Check Price and Availability of V029-2163, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-2163 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-2163
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-2163
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-2163 available by request